Article info
Arrhythmias and sudden death
Original research
Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk
- Correspondence to Dr Frederik Hendrik Verbrugge, Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven 3000, Belgium; frederik.verbrugge{at}zol.be
Citation
Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk
Publication history
- Received August 22, 2019
- Revised October 28, 2019
- Accepted November 3, 2019
- First published December 5, 2019.
Online issue publication
January 18, 2021
Article Versions
- Previous version (18 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.